Search for Clinical Trial Results

Mucopolysaccharidosis Type VI - 35 Studies Found
Status | Study |
Recruiting |
Study Name: Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome Condition: Maroteaux-Lamy Syndrome Date: 2014-06-03 Interventions: Drug: Naglazyme® 1 mg per kg of body weight administered once weekly as an intravenous infusion |
Completed |
Study Name: Study of rhASB in Patients With Mucopolysaccharidosis VI Condition: Mucopolysaccharidosis VI Date: 2005-02-24 Interventions:
|
Completed |
Study Name: Study of Recombinant Human N-Acetylgalactosamine 4-Sulfatase in Patients With MPS VI Condition: Mucopolysaccharidosis VI Date: 2002-11-04 Interventions: Drug: N-acetylgalactosamine 4-sulfatase |
Completed |
Study Name: Open-Label Study of Efficacy and Safety of Recombinant Human N-acetylgalactosamine 4-sulfatase in Patients With MPS VI Condition: Mucopolysaccharidosis VI Date: 2002-11-06 Interventions: Drug: N-acetylgalactosamine 4-sulfatase |
Completed |
Study Name: A Phase 4 Two Dose Level Study of Naglazyme(TM) (Galsulfase) in Infants With MPS VI Condition:
|
Recruiting |
Study Name: Biomarker for Maroteaux-Lamy Disease Condition:
Date: 2011-10-24 |
Completed |
Study Name: Study of Recombinant Human N-acetylgalactosamine 4-sulfatase (rhASB) in Patients With MPS VI Condition: Mucopolysaccharidosis VI Date: 2003-08-20 Interventions:
|
Recruiting |
Study Name: Mucopolysaccharidosis (MPS) VI Clinical Surveillance Program (CSP) Condition: Mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy Syndrome) Date: 2005-09-13 |
Completed |
Study Name: Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome Condition:
|